Systematic review and network meta-analysis of the efficacy, safety and tolerability of xanomeline plus trospium chloride compared with eight oral antipsychotics for the acute treatment of schizophren...

Effect of dose tapering policy on the prescription of advanced therapy for rheumatoid arthritis: a retrospective analysis of clinical and cost outcomes in Taiwan

Mortality risk estimation for autistic older adults: comparing novel machine-learning derived weights versus standard weights for the Charlson Comorbidity Index

Transparency in positive airway pressure therapy trials: an evaluation of reporting quality

Clinical effectiveness of a digitally delivered balance program for older adults: a nonrandomized controlled trial

Treatment burden and healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps who did or did not undergo functional endoscopic sinus surgery: a US real-world retrospec...

Why misaligned evidence strategies delay patient access to medicines | Becaris Publishing

Rare disease outcome assessment under EU HTA and joint clinical assessment | Becaris Publishing

Hot off the press: Part one of our pick of articles within HTA and RWE published in January 2026 | Becaris Publishing

Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trial

Head-to-head real-world study reports overall survival advantage with apalutamide compared with darolutamide in metastatic castration-sensitive prostate cancer | Becaris Publishing

Industry update tracker: January 2026 | Becaris Publishing

Patient roles and expectations in effective HTA engagement | Becaris Publishing

Indirect comparisons of tucatinib in combination with trastuzumab for patients with previously treated HER2–positive metastatic colorectal cancer

CMS announces drugs selected for third cycle of Medicare drug price negotiations | Becaris Publishing

Acthar Gel versus standard of care for adults with proteinuria in nephrotic syndrome due to focal segmental glomerulosclerosis: cost-per-response analysis from the US healthcare perspective

Modeling caregiver quality of life in HTA: Why economic models struggle to reflect lived experience | Becaris Publishing

First-line tumor necrosis factor inhibitor versus abatacept treatment choice in real-world patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritis

New in the Journal of Comparative Effectiveness Research: Video Snapshots | Becaris Publishing

FDA draft guidance clarifies use of Bayesian methods in clinical trials | Becaris Publishing

Reshaping the cardiovascular continuum in the management of arterial and venous cardiovascular disease: a narrative review

Health Canada opens consultation on draft guidance for decentralized clinical trials | Becaris Publishing

The impact of socioeconomic crisis on cancer patient outcomes in Lebanon, 2018–2020

Comparison of deep prostate-specific antigen response in Black patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamide

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Becaris Publishing

Lessons from a pilot study on AI coding and analysis of qualitative patient data | Becaris Publishing